On behalf of the SFGM-TC: retrospective comparison of reduced and higher intensity conditioning for high-risk myelodysplastic syndrome treated with allogeneic stem-cell transplantation

Allogeneic hematopoietic stem-cell transplantation (allo-HSCT) remains the best curative option for high-risk myelodysplastic syndrome (MDS). We retrospectively compared patient outcomes after allo-HSCT according to the intensity of the conditioning regimen.

Source: Clinical Lymphoma, Myeloma and Leukemia - August 2, 2021 Category: Hematology Authors: Arnaud Campidelli, Marie Robin, Thomas Remen, Amandine Luc, H élène Labussière-Wallet, Rémi Dulery, Micha Srour, Patrice Ceballos, Edouard Forcade, Stephanie Nguyen-Quoc, Sabine Furst, Pascal Turlure, Jacques-Olivier Bay, Célestine Simand, Ambroise M Source Type: research